A 2021 review published in Nutrients found that GLP-1 receptor agonist use was associated with reduced dietary intake of multiple micronutrients including B12, particularly in patients following calorie-restricted eating patterns, supporting the rationale for monitoring B12 status during treatment even in patients without pre-existing deficiency risk factors
The current NICE guidance on B12 and folate deficiency sets this out clearly
You need to understand what the clinical trials found, what real users experience, what separates normal adjustment from genuine concern, and what you can do to minimize unwanted effects
When combined with semaglutide, it creates a powerful dual therapy thats being studied for even greater weight loss than semaglutide alone.
Injectable for systemic effects and fastest results
Pregnant or Breastfeeding Women: The increased nutritional needs during pregnancy and breastfeeding may require B12 supplementation to support both mother and child
